Bio-Rad Laboratories ddSEQ Single-Cell 3′ RNA-Seq Kit
20 June, 2024The kit delivers high-quality single-cell 3′ RNA-Seq libraries in a fast, efficient workflow, allowing researchers to easily conduct single-cell gene expression and regulation analyses.
Twist Multiplexed Gene Fragments
17 June, 2024Twist Multiplexed Gene Fragments offer a novel pooled format for up to hundreds of thousands of gene fragments, between 301 and 500 base pairs in length.
Gene therapy for frontotemporal dementia
13 June, 2024A new therapeutic approach for treating frontotemporal dementia — an incurable brain disease — uses modified viruses to replace a missing protein in the brain.
Revvity Horizon Discovery Pin-point Base Editing Platform
24 May, 2024The Horizon Discovery Pin-point Base Editing platform from Revvity, with its novel three-part design and strong safety profile, is designed to enhance base editing's capabilities by enabling simultaneous modification of several genes at once.
ACROBiosystems target antigens for CAR-T therapy development
24 May, 2024ACROBiosystems' growing list of proteins includes many fluorescent-labelled target antigens and pre-biotinylated proteins that are suitable for evaluating CAR expression.
Cell-mapping project to uncover genetic fingerprints of disease
22 May, 2024The $27m project will see researchers map 50 million human cells from 10,000 people to identify unique genomic fingerprints of autoimmune diseases, heart diseases and cancer.
Fast growth during puberty linked to long-term health conditions
20 May, 2024Being taller at early puberty and experiencing quicker pubertal growth were associated with an increased risk of atrial fibrillation — an irregular and abnormally fast heart rate.
Gene editing could make quolls resistant to cane toad toxin
14 May, 2024Scientists from Colossal Biosciences and The University of Melbourne have introduced genetic resistance against the cane toad toxin into marsupial cells.
Genetic cause found for rare neurological disease
09 May, 2024The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare movement disorder with no known cure and, until recently, no known cause.
OGT SureSeq Myeloid Fusion Panel
07 May, 2024The RNA-based SureSeq Myeloid Fusion Panel is a next-generation sequencing (NGS) tool for identifying key fusion genes implicated in acute myeloid leukaemia (AML).
Researchers find the 'switch' that deactivates brown fat
06 May, 2024Researchers have found a protein that is responsible for turning off brown fat activity, in a breakthrough which could help to address obesity and related health problems.
Personality influences the expression of our genes
18 April, 2024An international research team has used artificial intelligence to show that our personalities alter the expression of our genes, and thus affect our health and wellbeing.
Gene discovery offers hope for new kidney disease treatments
15 April, 2024Researchers have identified a gene that plays a crucial role in regulating energy supply to cells that drive kidney failure.
Inhibiting MERTK gene treats fibrosis in multiple organs
08 April, 2024New research confirms the role of MERTK in multiple organ fibrosis and could lead to the development of much-needed anti-fibrotic treatments.
A novel technique for creating human artificial chromosomes
02 April, 2024The new method allows human artificial chromosomes to be crafted quickly and precisely, which will speed up the rate at which DNA research can be done.
